MSI Methylation Sciences Competitors and Similar CompaniesClear all
Alector's competitors and similar companies include Supernus Pharmaceuticals.
 Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2013 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ | Locations Rockville, US HQ |
Employees | Employees 2382% decrease | Employees 6527% increase |
Valuation ($) | Valuation ($) 495.3 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $719m (FY, 2025) |
Net income | Net income ($142.9m) (FY, 2025) | Net income ($38.6m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 194.5m | Total funding raised $ 69.5m |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company